CLINICAL_TRIALS
trial_result
· 2016-03-14
Clinical Trial Update: Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE) [Phase 2, Phase 3]
Summary
Completion and posted results of the APRIL-SLE Phase 2/3 trial evaluating atacicept in generalized systemic lupus erythematosus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMD Serono | Conditions: Lupus Erythematosus, Systemic | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-03-14